Product Code: ETC9962609 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Cloning & Mutagenesis Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Cloning & Mutagenesis Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Cloning & Mutagenesis Market - Industry Life Cycle |
3.4 United States (US) Cloning & Mutagenesis Market - Porter's Five Forces |
3.5 United States (US) Cloning & Mutagenesis Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 United States (US) Cloning & Mutagenesis Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 United States (US) Cloning & Mutagenesis Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United States (US) Cloning & Mutagenesis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Technological advancements in cloning and mutagenesis techniques leading to improved efficiency and accuracy. |
4.2.2 Increasing research and development activities in the biotechnology and pharmaceutical industries. |
4.2.3 Growing demand for genetically modified organisms for various applications such as agriculture, healthcare, and industrial processes. |
4.3 Market Restraints |
4.3.1 Ethical concerns and regulatory restrictions surrounding cloning and genetic manipulation. |
4.3.2 High costs associated with cloning and mutagenesis technologies, limiting adoption among smaller research institutions. |
4.3.3 Limited public acceptance and awareness of the benefits of cloning and genetic engineering. |
5 United States (US) Cloning & Mutagenesis Market Trends |
6 United States (US) Cloning & Mutagenesis Market, By Types |
6.1 United States (US) Cloning & Mutagenesis Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Cloning & Mutagenesis Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 United States (US) Cloning & Mutagenesis Market Revenues & Volume, By Cloning Kits, 2021- 2031F |
6.1.4 United States (US) Cloning & Mutagenesis Market Revenues & Volume, By Mutagenesis Kits, 2021- 2031F |
6.2 United States (US) Cloning & Mutagenesis Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Cloning & Mutagenesis Market Revenues & Volume, By Topo PCR Cloning, 2021- 2031F |
6.2.3 United States (US) Cloning & Mutagenesis Market Revenues & Volume, By Blunt End Cloning, 2021- 2031F |
6.2.4 United States (US) Cloning & Mutagenesis Market Revenues & Volume, By Seamless Cloning, 2021- 2031F |
6.2.5 United States (US) Cloning & Mutagenesis Market Revenues & Volume, By Site-directed Mutagenesis, 2021- 2031F |
6.2.6 United States (US) Cloning & Mutagenesis Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United States (US) Cloning & Mutagenesis Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Cloning & Mutagenesis Market Revenues & Volume, By Biopharmaceutical and Pharmaceutical Companies, 2021- 2031F |
6.3.3 United States (US) Cloning & Mutagenesis Market Revenues & Volume, By CROs and CMOs, 2021- 2031F |
6.3.4 United States (US) Cloning & Mutagenesis Market Revenues & Volume, By Academic and Research Institutes, 2021- 2031F |
7 United States (US) Cloning & Mutagenesis Market Import-Export Trade Statistics |
7.1 United States (US) Cloning & Mutagenesis Market Export to Major Countries |
7.2 United States (US) Cloning & Mutagenesis Market Imports from Major Countries |
8 United States (US) Cloning & Mutagenesis Market Key Performance Indicators |
8.1 Research and development investment in cloning and mutagenesis technologies. |
8.2 Number of patents granted for cloning and mutagenesis innovations. |
8.3 Adoption rate of genetically modified organisms in key industries. |
8.4 Number of academic and industry collaborations in the field of cloning and mutagenesis. |
8.5 Percentage of successful gene editing and cloning experiments in research studies. |
9 United States (US) Cloning & Mutagenesis Market - Opportunity Assessment |
9.1 United States (US) Cloning & Mutagenesis Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United States (US) Cloning & Mutagenesis Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 United States (US) Cloning & Mutagenesis Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United States (US) Cloning & Mutagenesis Market - Competitive Landscape |
10.1 United States (US) Cloning & Mutagenesis Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Cloning & Mutagenesis Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |